Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD) and anemia, targeting higher hemoglobin levels with an erythropoietic agent is not helpful and is very…
NEW YORK (Reuters Health) – Amlodipine decreases central systolic blood pressure more effectively when combined with valsartan than with atenolol, French researchers reported online April 19th in Hypertension.…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…
NEW YORK (Reuters Health) – In patients with diabetic nephropathy, high doses of B vitamins accelerate kidney dysfunction and increase the rate of myocardial infarction (MI) and strokes,…
NEW YORK (Reuters Health) – A study published today provides more evidence that proton pump inhibitors (PPI) interfere with clopidogrel. Recommendations from the Society for Cardiovascular Angiography and…
NEW YORK (Reuters Health) – Patients with vascular dementia who took the acetylcholinesterase inhibitor donepezil had mild improvements in cognitive function, but not global function, in an international…
NEW YORK (Reuters Health) – The TNF alpha inhibitor adalimumab provides minor analgesia in patients with radicular pain due to lumbar disc herniation, but prompts a major reduction…
NEW YORK (Reuters Health) – Physicians should monitor serum testosterone levels during androgen-deprivation therapy (ADT) in men with prostate cancer, according to an April 16th online report in…
NEW YORK (Reuters Health) – Using recombinant tissue plasminogen activator (rtPA) within existing licensing limits is fully justified by available data – but there’s not enough data to…
NEW YORK (Reuters Health) – The angiotensin II receptor blocker olmesartan medoxomil (Benicar) significantly reduces blood pressure in children with primary or secondary hypertension, according to an international…
